Skvarka Jan
CIK 0001838042
Director
Filings
9
Latest Jun 18, 2025
Issuers covered
2
Showing
9 of 9
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 100% | +16.7% | +16.7% | +23.1% | +10.3% |
| 90 days | 2 | 50% | +16.0% | +16.0% | +48.7% | -16.7% |
| 180 days | 2 | 50% | +11.7% | +11.7% | +44.1% | -20.7% |
| 365 days | 2 | 100% | +65.6% | +65.6% | +86.9% | +44.3% |
Issuers
Companies where Skvarka Jan has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals, Inc. | 5 | Jun 18, 2025 |
| GLUE | Monte Rosa Therapeutics, Inc. | 4 | Jun 16, 2025 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|